Healthcare provider profile · identity verified

Lori George

Family Practice · TEXARKANA, AR · NPI 1760041180

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	275	46
Atorvastatin Calcium	Atorvastatin Calcium	195	73
Gabapentin	Gabapentin	182	65
Furosemide	Furosemide	156	57
Pantoprazole Sodium	Pantoprazole Sodium	129	56
Amlodipine Besylate	Amlodipine Besylate	125	54
Potassium Chloride	Potassium Chloride	114	47
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	112	47
Albuterol Sulfate Hfa	Albuterol Sulfate	107	45
Prednisone	Prednisone	94	76
Tramadol Hcl	Tramadol Hcl	89	28
Ozempic	Semaglutide	87	19
Glimepiride	Glimepiride	85	33
Lisinopril	Lisinopril	84	29
Metformin Hcl	Metformin Hcl	75	24
Levothyroxine Sodium	Levothyroxine Sodium	74	28
Tizanidine Hcl	Tizanidine Hcl	73	24
Alprazolam	Alprazolam	72	17
Omeprazole	Omeprazole	70	29
Losartan Potassium	Losartan Potassium	69	27
Buspirone Hcl	Buspirone Hcl	68	26
Fluticasone Propionate	Fluticasone Propionate	62	28
Trazodone Hcl	Trazodone Hcl	60	23
Hydroxyzine Hcl	Hydroxyzine Hcl	57	25
Triamcinolone Acetonide	Triamcinolone Acetonide	57	34
Ropinirole Hcl	Ropinirole Hcl	54	15
Pregabalin	Pregabalin	53	suppressed
Methocarbamol	Methocarbamol	51	22
Metoprolol Succinate	Metoprolol Succinate	49	23
Lorazepam	Lorazepam	48	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	47	40
Ondansetron Odt	Ondansetron	47	24
Metoprolol Tartrate	Metoprolol Tartrate	45	17
Carvedilol	Carvedilol	44	21
Escitalopram Oxalate	Escitalopram Oxalate	44	20
Ibuprofen	Ibuprofen	44	17
Dicyclomine Hcl	Dicyclomine Hcl	41	19
Eliquis	Apixaban	41	13
Tamsulosin Hcl	Tamsulosin Hcl	41	16
Mounjaro	Tirzepatide	40	suppressed
Duloxetine Hcl	Duloxetine Hcl	39	16
Hydrochlorothiazide	Hydrochlorothiazide	39	19
Naproxen	Naproxen	38	13
Meclizine Hcl	Meclizine Hcl	37	14
Jardiance	Empagliflozin	36	suppressed
Oxycodone Hcl	Oxycodone Hcl	36	suppressed
Celecoxib	Celecoxib	34	18
Diclofenac Sodium	Diclofenac Sodium	34	11
Famotidine	Famotidine	34	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	13
Meloxicam	Meloxicam	34	16
Diclofenac Potassium	Diclofenac Potassium	33	11
Levofloxacin	Levofloxacin	33	28
Methylprednisolone	Methylprednisolone	32	29
Oxybutynin Chloride Er	Oxybutynin Chloride	32	11
Clonidine Hcl	Clonidine Hcl	31	13
Fluconazole	Fluconazole	31	20
Azithromycin	Azithromycin	30	21
Montelukast Sodium	Montelukast Sodium	30	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	30	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	30	suppressed
Primidone	Primidone	28	suppressed
Spironolactone	Spironolactone	28	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	28	suppressed
Allopurinol	Allopurinol	27	12
Rosuvastatin Calcium	Rosuvastatin Calcium	27	18
Azelastine Hcl	Azelastine Hcl	25	12
Farxiga	Dapagliflozin Propanediol	25	suppressed
Pravastatin Sodium	Pravastatin Sodium	25	suppressed
Clonazepam	Clonazepam	24	11
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	24	suppressed
Bupropion Xl	Bupropion Hcl	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	13
Acetaminophen-Codeine	Acetaminophen With Codeine	22	suppressed
Chlorthalidone	Chlorthalidone	22	14
Januvia	Sitagliptin Phosphate	22	suppressed
Linzess	Linaclotide	22	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	21	11
Sertraline Hcl	Sertraline Hcl	21	suppressed
Simvastatin	Simvastatin	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Symbicort	Budesonide/Formoterol Fumarate	19	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Glipizide	Glipizide	18	suppressed
Trulicity	Dulaglutide	18	suppressed
Aripiprazole	Aripiprazole	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Mupirocin	Mupirocin	17	suppressed
Nystatin	Nystatin	17	suppressed
Clopidogrel	Clopidogrel Bisulfate	16	11
Eszopiclone	Eszopiclone	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Prazosin Hcl	Prazosin Hcl	16	suppressed
Temazepam	Temazepam	16	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Promethazine Hcl	Promethazine Hcl	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Valsartan	Valsartan	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Lidocaine Hcl Viscous	Lidocaine Hcl	14	14
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Baclofen	Baclofen	13	suppressed
Estradiol	Estradiol	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Topiramate	Topiramate	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Citalopram Hbr	Citalopram Hydrobromide	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error